Business

Wintour gave people something to aspire to, setting a standard of excellence and creativity. That matters.Read More

Industry insiders shared their fears and concerns in a recent ADWEEK reader survey.Read More

Laszewski has been the news director at Gray Television’s WMTV in Madison, Wisconsin since October 2017.Read More

CNN took second place in the demo, with MSNBC finishing in third position.Read More

Hamilton most recently served as market sales manager for the stationsRead More

Paul McGonagle and Amber Eikel have been promoted.Read More

The New York Times also received a similar letter threatening a lawsuit.Read More

Bloomberg reported that Nintendo pulled its products from Amazon due to illegal third-party activity.Read More

Gavin Newsom is seeking $787 million from Fox News.Read More

The NATO Innovation Fund (NIF) has made its first investment in a biotechnology startup. The alliance’s VC arm announced today that it’s co-leading a $35mn Series A round for UK-based Portal Biotech as it seeks to strengthen NATO’s defences against biological warfare. Portal develops portable, AI-powered diagnostic devices capable of detecting pathogens at the single-molecule level. Unlike traditional lab-based systems, its platform is designed for field deployment. It aims to offer rapid, on-site identification of biological threats.  Ana Bernardo-Gancedo, senior associate at NATO Innovation Fund, told Reuters that this capability is crucial for defence and security. “We believe it is…

This story continues at The Next WebRead More